Objective: To evaluate different patterns of after-contraction (A-C) waves detected during urodynamic evaluation in women. Patients and Methods: 4,110 women were prospectively observed regarding the presence of A-C waves upon urodynamic evaluation. Intravenous pyelography and ultrasound were requested. Paired t test, χ2 test, Wilcoxon's rank sum test and correlation analysis were performed with a 95% significance level. Results: There were three distinguishing patterns of A-C: type I - detrusor contraction after the regular voiding phase, type II - detrusor contraction persisting after the flow rate had stopped, and type III - rebound of the detrusor contraction after the flow. A-C was observed in 13.9% of the women. Type I A-C wave patterns were present in 68 patients (11.8%), type II A-C wave patterns in 477 patients (83.2%), and type III A-C wave patterns in 28 patients (10.3%). Studies with intravenous pyelography and ultrasound very frequently showed bladder mucosa, muscle thickening or trabeculation. Secondary ureterectasis related to A-C waves was also observed. Additionally, watts factor, maximum flow rate, detrusor pressure and opening detrusor pressure were markedly elevated in patients with type III A-C, suggesting enhanced detrusor contraction in these A-C waves. Conclusion: A-C waves are a real urodynamic entity with different patterns of presentation and with clinical and morphological alterations.

Keywords:
Incontinence, Urodynamics, Detrusor, Bladder, Voiding dysfunctions
1.
Webster GD, Koefoot RB, Zakrzewski JB, Todd S: The after-contraction in urodynamic micturition studies. Neurourol Urodyn 1983;2:213-218.
2.
Vereecken RL: The after-contraction: a true detrusor contraction or a late dyssynergic urethral sphincter contraction? BJU Int 2000;85:246-248.
3.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society: The standardization of terminology of lower urinary tract function: report from the standardization Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.
4.
Massey JA, Abrams PH: Obstructed voiding in the female. Br J Urol 1988;61:36-42.
5.
Zinner NR, Paquim AJ: Clinical urodynamics. I. Studies of infravesical pressure in normal human female subjects. J Urol 1963;90:719-730.
6.
Hoebecke PB, Van Gool JD, Van Laecke E, Vandewalle J, Plancke H: The after-contraction in paediatric urodynamics. Br J Urol 1996;78:780-782.
7.
Ruarte AC, Podesta ML, Mendel R: Detrusor after-contraction in children with normal urinary tracts. BJU Int 2002;90:286-293.
8.
Cho SY, Yi SJ, Park JH, Jeong MS, Oh SJ: Detrusor after-contraction is associated with bladder outlet obstruction. Neurourol Urodyn 2011;30:1361-1365.
9.
Azadzoi JKM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB: Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999;162:1768-1778.
10.
Cucchi A: Sequential changes in voiding dynamics related to the development of detrusor instability in women with stress urinary incontinence. Neurourol Urodyn 1999;18:73-80.
11.
Elbadawi A, Yalla SV, Resnick NM: Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 1993;150:1668-1680.
12.
Cucchi A: Some observations on a condition of relatively lower detrusor contractility in stable versus unstable unobstructed bladders. Neurourol Urodyn 1995;14:317-324.
13.
Cucchi A: Bladder contractility and idiopathic detrusor instability in males. Neurourol Urodyn 1994;13:627-635.
14.
Koff SA, Wagner TT, Jayanthi VR: The relationship among dysfunctional elimination syndrome syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998;160:1019-1022.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.